Trump announces 2-year delay before 100% generic drug tariffs

President Donald Trump announced on Tuesday, July 21, 2026, that he plans to impose steep tariffs on imported generic pharmaceuticals, setting a concrete timeline for a policy shift that had previously exempted this critical drug category. The plan calls for a two-year grace period before a 100 percent tariff takes effect in August 2028, followed by a 200 percent tariff in August 2029.

The announcement, made via a social media post, extends a broader pharmaceutical trade strategy the administration has pursued. Trump stated the move is intended to force the reshoring of generic drug production to the United States, with penalties for companies that do not build manufacturing plants and equipment within the given timeframe. He emphasized that the administration's existing tariff policy for patented, branded drugs would remain unchanged.

Generic drugs, which include common medications like statins, antibiotics, and birth control pills, account for approximately 90 percent of all prescriptions filled in the United States. The vast majority of these drugs and their active ingredients are manufactured overseas, primarily in India with significant reliance on China, a supply chain...